Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

larotrectinib

larotrectinib
  • Non-formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vitrakvi CAPSULE, ORAL 25 mg, 100 mg      
Vitrakvi SOLUTION, ORAL 20 mg/mL      
Comments:

At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy") 

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Non-formulary, not stocked. Defer initation until after discharge. Inpatients may use home suppy.

Reviewed: 23 April 2019 (Vitrakvi capsule and solution)

Last updated: Mar. 10, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved